NCT07641192

Brief Summary

The aim of this randomized, blinded, controlled study is to compare the theranovis dental gel with a placebo product in order to determine whether an improvement in oral health can be achieved in patients with gingivitis.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jun 2026Apr 2027

First Submitted

Initial submission to the registry

May 26, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 11, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

June 11, 2026

Status Verified

June 1, 2026

Enrollment Period

10 months

First QC Date

May 26, 2026

Last Update Submit

June 8, 2026

Conditions

Keywords

theranovis dental gelgingivitis

Outcome Measures

Primary Outcomes (1)

  • BOP - bleeding on probing

    Change in Bleeding on Probing (BOP) percentage

    8 weeks

Secondary Outcomes (2)

  • PI - Plaque Index

    8 weeks

  • PBI - Papillary bleeding index

    8 weeks

Study Arms (2)

theranovis dental gel group

ACTIVE COMPARATOR

Ten participants will receive the theranovis dental gel

Other: theranovis dental gel group

Placebo group

PLACEBO COMPARATOR

Ten participants will receive the placebo product

Other: Placebo group

Interventions

The dental gel should be applied with a manual toothbrush every morning and evening after toothbrushing, left in place for 30 seconds without swallowing, and then spat out without rinsing with water afterward.

Also known as: Placebo group
theranovis dental gel group

The dental gel should be applied with a manual toothbrush every morning and evening after toothbrushing, left in place for 30 seconds without swallowing, and then spat out without rinsing with water afterward.

Placebo group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female participants aged over 18 years
  • At least 12 teeth per jaw (natural teeth, including restorations such as crowns and implants)
  • Smokers (less than 10 cigarettes per day)
  • Gingivitis with intact periodontium (probing depth ≤ 3.0 mm, bleeding on probing \> 10%)
  • Gingivitis with intact periodontium (probing depth ≤ 4 mm, no bleeding on probing at these sites)
  • Periodontal screening index (PSI) up to grade 2

You may not qualify if:

  • Male and female participants under 18 years of age
  • Fewer than 12 teeth per jaw
  • Individuals not capable of giving informed consent
  • Individuals with hypersensitivity or allergies to any of the study product ingredients
  • Patients with periodontitis
  • Patients with non-plaque-induced gingivitis
  • Periodontal screening index (PSI) grade 3 or higher
  • Current antibiotic prophylaxis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsklinik für Zahnmedizin und Mundgesundheit

Graz, Styria, 8010, Austria

Location

MeSH Terms

Conditions

Gingivitis

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Central Study Contacts

Behrouz Arefnia,, Univ. ZA Dr.scient.med.dent.

CONTACT

Julia Lüftenegger

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2026

First Posted

June 11, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

June 11, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

The data will be used exclusively for the conduct of the diploma thesis study.

Locations